Condition 101 About Macular Corneal Dystrophy Type 1

Condition 101 content is not available at this time, but we are continually updating the site. Please check back.

However, there may be experts who have treated this or similar conditions in our Find a Doctor section and research may be available in our Latest Advances section.

Top Global Doctors For Macular Corneal Dystrophy Type 1

View All Doctors

Latest Advances On Macular Corneal Dystrophy Type 1

  • Condition: Fuchs Endothelial Dystrophy and Cataract
  • Journal: Vestnik oftalmologii
  • Treatment Used: Femtosecond Laser-assisted Descemet Stripping Endothelial Keratoplasty Versus Microkeratome-assisted Descemet Stripping Automated Endothelial Keratoplasty
  • Number of Patients: 37
  • Published —
In this study, researchers compared the outcomes of femtosecond laser-assisted Descemet stripping endothelial keratoplasty versus microkeratome-assisted Descemet Stripping Automated Endothelial Keratoplasty when used as treatment for Fuchs endothelial dystrophy and cataract.
  • Condition: Neurotrophic Keratitis in Patients with Facial Paralysis
  • Journal: Vestnik oftalmologii
  • Treatment Used: Neurotization of Cornea
  • Number of Patients: 0
  • Published —
This article discusses neurotization of the cornea as a treatment for neurotrophic keratitis (cornea inflammation) in patients with facial paralysis.
View All Latest Advances

Clinical Trials For Macular Corneal Dystrophy Type 1

Clinical Trial
  • Status: Recruiting
  • Intervention Type: Diagnostic Test
  • Participants: 150
  • Start Date: November 21, 2020
Incidence of Post-operative Cystoid Macular Edema: A Prospective Study Comparing DMEK, DSEK, and DSO
Clinical Trial
  • Status: Recruiting
  • Phase: Phase 2
  • Intervention Type: Drug
  • Participants: 45
  • Start Date: November 6, 2020
Targeting Reactive Oxygen Species Production as a Novel Therapeutic in Fuch's Endothelial Corneal Dystrophy
View All Clinical Trials